Approvals/FDA/Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride

Approved

HUMAN PRESCRIPTION DRUG LABEL

0c8b195800da217a

Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride

Ingenus Pharmaceuticals, LLC🇺🇸 United States

FDA Page

Effective Date: Dec 13, 2022
Approval ID: 4c7f024d-ba26-43cf-a36f-597e2168cd9f
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES. BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, and TETRACYCLINE HYDROCHLORIDE capsules, for oral useInitial U.S. Approval: 2006

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.